|
Volumn 153, Issue 3, 2001, Pages 645-649
|
Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders
|
Author keywords
Cre recombinase; Epidermolytic hyperkeratosis; Gene therapy; Keratins; Mosaic skin disease
|
Indexed keywords
CRE RECOMBINASE;
KERATIN;
CYTOKERATIN 10;
INTEGRASE;
KRT1 10 PROTEIN, MOUSE;
KRT1-10 PROTEIN, MOUSE;
KRT10 PROTEIN, HUMAN;
MIFEPRISTONE;
VIRUS PROTEIN;
ALLELISM;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CELL FUNCTION;
CONTROLLED STUDY;
GENE ACTIVATION;
GENE MUTATION;
GENE THERAPY;
GENETIC MODEL;
HYPERKERATOSIS;
MOSAICISM;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PATHOGENESIS;
PHENOTYPE;
PRIORITY JOURNAL;
SKIN BIOPSY;
SKIN DISEASE;
SOMATIC CELL GENETICS;
STEM CELL;
ANIMAL;
CONGENITAL ICHTHYOSIFORM ERYTHRODERMA;
DISEASE MODEL;
DRUG EFFECT;
FEMALE;
GENE TARGETING;
GENETICS;
HUMAN;
METABOLISM;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
POINT MUTATION;
SKIN;
TRANSGENIC MOUSE;
ANIMALIA;
ANIMALS;
DISEASE MODELS, ANIMAL;
FEMALE;
GENE TARGETING;
HUMANS;
HYPERKERATOSIS, EPIDERMOLYTIC;
INTEGRASES;
KERATIN-10;
KERATINS;
MICE;
MICE, TRANSGENIC;
MIFEPRISTONE;
MOSAICISM;
POINT MUTATION;
SKIN;
STEM CELLS;
VIRAL PROTEINS;
|
EID: 0035809167
PISSN: 00219525
EISSN: None
Source Type: Journal
DOI: 10.1083/jcb.152.3.645 Document Type: Article |
Times cited : (67)
|
References (31)
|